Author | Kevin Kalinsky, MD, MS | OncLive

Author | Kevin Kalinsky, MD, MS

Articles

Dr. Kalinksy on pCR as a Surrogate Marker for EFS in TNBC

April 03, 2020

Video

Kevin Kalinsky, MD, MS, assistant professor of medicine, Division of Hematology and Oncology, NewYork-Presbyterian Hospital/Columbia University Medical Center, discusses the use of pathologic complete response (pCR) rate as a surrogate marker for event-free survival (EFS) in triple-negative breast cancer (TNBC).

Dr. Kalinsky on Clinical Impact of Atezolizumab Combo in TNBC

January 31, 2020

Video

Kevin Kalinsky, MD, MS, discusses the clinical impact of the combination of atezolizumab and nab-paclitaxel in triple-negative breast cancer.

Dr. Kalinsky on CNS Involvement in HER2+ Breast Cancer

September 20, 2018

Video

Kevin Kalinsky, MD, MS, assistant professor of medicine, Division of Hematology and Oncology, NewYork-Presbyterian Hospital/Columbia University Medical Center, discusses central nervous system involvement in HER2-positive breast cancer.

Dr. Kalinsky Discusses the Evolution of HER2+ Breast Cancer

September 05, 2018

Video

Kevin Kalinsky, MD, MS, assistant professor of medicine, Division of Hematology and Oncology, NewYork-Presbyterian Hospital/Columbia University Medical Center, discusses the evolution of treatment for patients with HER2-positive metastatic breast cancer.

x